Approval · Notice of Compliance 12822 · 2011
DIVIGEL: Notice of Compliance 12822
Issued December 1, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12822
- Date
- December 1, 2011
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Estrogens
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIVIGEL | 02377098 | Cancelled Post Market |
Medicinal ingredients
- ESTRADIOL 0.1 PER